These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2147547)

  • 1. Activated T-lymphocytes in newly diagnosed type I diabetic patients: relationship to residual beta cell function.
    Binimelis J; Codina M; Oriola J; Amill B; Perez A; de Leiva A
    J Autoimmun; 1990 Oct; 3(5):579-85. PubMed ID: 2147547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 years.
    Bardet S; Rohmer V; Maugendre D; Valentin A; Gallois Y; Stetieh H; Marre M; Allannic H; Charbonnel B; Sai P
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1310-7. PubMed ID: 2146283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
    Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
    J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
    Peakman M; Warnock T; Vats A; McNab GL; Underhill J; Donaldson PT; Vergani D
    Diabetologia; 1994 Feb; 37(2):155-65. PubMed ID: 8163049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte subsets and activation in prediabetes.
    Hitchcock CL; Riley WJ; Alamo A; Pyka R; Maclaren NK
    Diabetes; 1986 Dec; 35(12):1416-22. PubMed ID: 3533686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
    Baker C; Chang L; Elsegood KA; Bishop AJ; Gannon DH; Narendran P; Leech NJ; Dayan CM
    Clin Exp Immunol; 2007 Mar; 147(3):472-82. PubMed ID: 17302896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.
    Kaaba SA; Al-Harbi SA
    Immunol Lett; 1995 Sep; 47(3):209-13. PubMed ID: 8747721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.
    Rharbaoui F; Mayer A; Granier C; Bouanani M; Thivolet C; Pau B; Orgiazzi J; Madec AM
    Clin Exp Immunol; 1999 Jul; 117(1):30-7. PubMed ID: 10403912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of T cells in newly diagnosed insulin-dependent diabetic patients: evidence for heterogeneity of T cell receptor usage.
    Kontiainen S; Toomath R; Lowder J; Feldmann M
    Clin Exp Immunol; 1991 Mar; 83(3):347-51. PubMed ID: 1825939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent activation of CD8+ T-cells characterizes prediabetic twins.
    Peakman M; Leslie RD; Alviggi L; Hawa M; Vergani D
    Diabetes Care; 1996 Nov; 19(11):1177-84. PubMed ID: 8908376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.
    Monetini L; Barone F; Stefanini L; Petrone A; Walk T; Jung G; Thorpe R; Pozzilli P; Cavallo MG
    J Endocrinol; 2003 Jan; 176(1):143-50. PubMed ID: 12525258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.
    Krug J; Bierwolf B; Lampeter E; Verlohren HJ; Lohmann D
    Clin Exp Immunol; 1991 Apr; 84(1):43-7. PubMed ID: 1826646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated lymphocytes in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus.
    Sugihara S; Kohno Y; Miyamoto S; Sasaki N; Niimi H; Nakajima H
    Endocrinol Jpn; 1986 Jun; 33(3):385-93. PubMed ID: 3093206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus.
    Legendre CM; Schiffrin A; Weitzner G; Colle E; Guttmann RD
    Diabetes; 1988 Jun; 37(6):792-5. PubMed ID: 3290000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.